Clinical Trials in Houston

Showing 5341-5360 of 13,620 trials

Study Investigating NTLA-5001 in Subjects With Acute Myeloid Leukemia

NCT05066165

This study will be conducted to evaluate the safety, tolerability, cellular kinetics (CK), activity, and pharmacodynamics (PD) of NTLA-5001 in participants with Acute Myeloid Leukemia (AML).

Acute Myeloid Leukemia

Intellia Therapeutics6 participantsStarted Dec 2021

Los Angeles, California, United States • Tampa, Florida, United States • Boston, Massachusetts, United States +7 more locations

COMPLETEDPhase 3< 1 mile

Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss

NCT02008357

The purpose of this study is to test whether an investigational drug called solanezumab can slow the progression of memory problems associated with brain amyloid (protein that forms plaques in the brains of people with Alzheimer Disease \[AD\]).

Cognition Disorders

Eli Lilly and Company1,169 participantsStarted Feb 2014

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +65 more locations

Study Investigating NTLA-5001 in Subjects With Acute Myeloid Leukemia

Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss

Find Trials by Condition in Houston

Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine

VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Study to Evaluate the Safety and Efficacy of KITE-439 in HLA-A*02:01+ Adults With Relapsed/Refractory HPV16+ Cancers

Transseptal vs Retrograde Aortic Ventricular Entry to Reduce Systemic Emboli

Interferon Alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant Meningiomas

A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple Sclerosis

A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Moderate-to-Severe Atopic Hand and Foot Dermatitis (Liberty-AD-HAFT)

Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19

A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma

Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer

A Study of TAK-994 in Adults With Narcolepsy

MSB11022 in Moderate to Severe Chronic Plaque Psoriasis

A Phase I Pharmacokinetic Study of TVB-2640 (Denifanstat) in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Function

Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma

Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis

A Study of Lanadelumab in Teenagers and Adults to Prevent Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH)

CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With Nivolumab

Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation